Steven Andrew Roy
Nursing at Grant St, Denver, CO
License number
Colorado 120978
Issued Date
Mar 8, 1999
Renew Date
Oct 1, 2016
Expiration Date
Sep 30, 2018
Type
Registered Nurse
Address
Address
268 Grant St, Denver, CO 80203
Professional information
President &Amp; Ceo, Vetdc, Inc., A Cancer-Based Veterinary Biotechnology Company
Position:
President & CEO at VetDC
Location:
Greater Denver Area
Industry:
Biotechnology
Work:
VetDC
- Ft. Collins, CO since Feb 2010
-
President & CEO
ENTROPY2ACTION, LLC
Sep 2009 - Feb 2010
-
Co-Founder
AMGEN INC.
Jan 2004 - Nov 2007
-
Director, Licensing/Alliance Management
AMGEN INC
Jan 2001 - Dec 2003
-
Sr. Associate Director, Aranesp Oncology Planning & Operations
AMGEN INC.
Jan 1999 - Jan 2001
-
Associate Director, Market Research
AMGEN INC.
Jan 1997 - Jan 1999
-
Associate Director, Corporate Development
AMGEN INC.
Jan 1994 - Jan 1997
-
Product Manager, New Products Marketing
LIGAND PHARMACEUTICALS INC
Jan 1988 - Jan 1992
-
Laboratory Supervisor
Education:
University of Michigan - Stephen M. Ross School of Business 1992 - 1994
MBA, Marketing, Finance UNIVERSITY OF CALIFORNIA AT SAN DIEGO 1983 - 1987
Bachelor of Arts, Molecular Biology
MBA, Marketing, Finance UNIVERSITY OF CALIFORNIA AT SAN DIEGO 1983 - 1987
Bachelor of Arts, Molecular Biology
Skills:
Biotechnology, Veterin, Veterinary, Strategic Alliances, Biopharmaceuticals, Oncology, Lifesciences, Pharmaceutical Industry, Commercialization, Technology Transfer, Clinical Development, Drug Discovery, Drug Development, Clinical Trials, Infectious Diseases, Medical Devices, Licensing, Immunology, FDA, Molecular Biology, Regulatory Affairs, CRO, R&D
Interests:
Triathlons, Backpacking, Snowboarding, Literary Classics, Outdoor Leadership
Honor & Awards:
Eagle Scout - Boy Scouts of America
Languages:
Spanish
Awards:
VetDC Wins Venture Showcase Competition at BioWest 2012
Colorado BioScience Association (CBSA)
DENVER, Sep 12, 2012 (BUSINESS WIRE) -- VetDC (Fort Collins) won the 2012 Venture Showcase competition at the 2012 BioWest Conference & Expo yesterday at the Marriott City Center Denver, receiving the $7,500 cash prize. The announcement is made by April Giles, Colorado BioScience Association (CBSA) Executive Vice President who says this year's Venture Showcase was made possible by sponsors Dorsey & Whitney LLP, EKS&H and The Metro Denver Economic Development Corporation. BioWest, the Rocky Mountain Region's premier medical device and biotechnology conference, is organized by the CBSA and held every other year. VetDC is an emergent veterinary biotechnology company that licenses innovative human biomedical technologies to address serious medical needs in companion animals. By aligning with CSU's top-ranked veterinary school, VetDC has unique capabilities to develop animal therapies, resulting in speed to market, risk reduction, and capital preservation. VetDC has assembled a proven team with regulatory, CMC, and clinical expertise. VetDC's lead candidate, VDC-1101, is an anti-cancer drug with extensive animal data. VDC-1101 is expected to launch in 2014 with $50M peak revenue potential. In 2011, VetDC secured funding from the Colorado Institute for Drug, Device and Diagnostic Development (CID4). VetDC President/CEO Steven Roy made the presentation at the Venture Showcase. For more information, visit: http://www.vet-dc.com . "The Venture showcase announcement is the capstone to the BioWest Conference," Giles explains. "It creates a huge buzz in the industry for the up-and-coming companies chosen to compete. We are very proud to announce VetDC as this year's winner."
Colorado BioScience Association (CBSA)
DENVER, Sep 12, 2012 (BUSINESS WIRE) -- VetDC (Fort Collins) won the 2012 Venture Showcase competition at the 2012 BioWest Conference & Expo yesterday at the Marriott City Center Denver, receiving the $7,500 cash prize. The announcement is made by April Giles, Colorado BioScience Association (CBSA) Executive Vice President who says this year's Venture Showcase was made possible by sponsors Dorsey & Whitney LLP, EKS&H and The Metro Denver Economic Development Corporation. BioWest, the Rocky Mountain Region's premier medical device and biotechnology conference, is organized by the CBSA and held every other year. VetDC is an emergent veterinary biotechnology company that licenses innovative human biomedical technologies to address serious medical needs in companion animals. By aligning with CSU's top-ranked veterinary school, VetDC has unique capabilities to develop animal therapies, resulting in speed to market, risk reduction, and capital preservation. VetDC has assembled a proven team with regulatory, CMC, and clinical expertise. VetDC's lead candidate, VDC-1101, is an anti-cancer drug with extensive animal data. VDC-1101 is expected to launch in 2014 with $50M peak revenue potential. In 2011, VetDC secured funding from the Colorado Institute for Drug, Device and Diagnostic Development (CID4). VetDC President/CEO Steven Roy made the presentation at the Venture Showcase. For more information, visit: http://www.vet-dc.com . "The Venture showcase announcement is the capstone to the BioWest Conference," Giles explains. "It creates a huge buzz in the industry for the up-and-coming companies chosen to compete. We are very proud to announce VetDC as this year's winner."
Rn At Denver Health
Position:
RN at Denver Health
Location:
Greater Denver Area
Industry:
Hospital & Health Care
Work:
Denver Health
-
RN